Skip to main content
BLLN logo
BLLN
(NASDAQ)
BillionToOne, Inc.
$128.94-- (--)
Loading... - Market loading

BillionToOne (BLLN) Stock Price & Financial Analysis

BillionToOne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$126.35 - $133.00
52-Week High$138.70
52-Week Low$61.96
Open$128.95
Volume462.80K
Average Volume (3M)720.20K
Market Cap6.84B
Shares Outstanding53.03M
P/E Ratio (TTM)223.04
Price to Sales (P/S)19.49
Price to Book (P/B)13.52
EV/EBITDA164.72
Revenue (TTM)350.73M
Net Income (TTM)30.66M
Free Cash Flow (TTM)28.05M
EPS (TTM)$0.78
Profit Margin8.74%
Operating Margin10.22%
Return on Equity (ROE)6.06%
Debt to Equity0.29
50-Day MA$106.77
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BillionToOne

What is the current stock price for BLLN?

As of the latest trading session, BLLN stock trades at $128.94. The 52-week range is $61.96–$138.70, with a day range of $126.35–$133.00.

What is the P/E ratio for BLLN?

BillionToOne's trailing P/E ratio is 223.0, meaning investors pay $223.0 for every $1 of annual earnings. BillionToOne operates in the Healthcare sector.

Does BLLN pay dividends?

BillionToOne does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLLN?

Based on 7 analysts, the consensus for BLLN is Buy.

What is the market cap of BLLN?

BillionToOne's market capitalization is $6.84B, classifying it as a mid-cap company. BillionToOne operates in the Healthcare sector within the Diagnostics & Research industry.